|
NUP160 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.666200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.082400E-01 |
| Normal-vs-Stage2 |
9.160400E-01 |
| Normal-vs-Stage3 |
3.434600E-01 |
| Normal-vs-Stage4 |
3.964800E-01 |
| Stage1-vs-Stage2 |
7.491400E-01 |
| Stage1-vs-Stage3 |
1.457150E-01 |
| Stage1-vs-Stage4 |
7.584800E-01 |
| Stage2-vs-Stage3 |
4.204400E-01 |
| Stage2-vs-Stage4 |
5.518800E-01 |
| Stage3-vs-Stage4 |
2.748400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.260000E-01 |
| Normal-vs-AfricanAmerican |
4.927400E-01 |
| Normal-vs-Asian |
3.770400E-01 |
| Caucasian-vs-AfricanAmerican |
3.871600E-01 |
| Caucasian-vs-Asian |
4.547600E-01 |
| AfricanAmerican-vs-Asian |
5.339800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.947400E-01 |
| Normal-vs-Female |
2.132600E-01 |
| Male-vs-Female |
8.791700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.798440E-01 |
| Normal-vs-Extreme_Weight |
2.810000E-01 |
| Normal-vs-Obese |
3.398400E-01 |
| Normal-vs-Extreme_Obese |
3.930800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.719800E-01 |
| Normal_Weight-vs-Obese |
6.303700E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.668600E-01 |
| Extreme_Weight-vs-Obese |
9.176500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.605200E-01 |
| Obese-vs-Extreme_Obese |
2.662200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.859390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.569400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.677620E-01 |
| Normal-vs-Age(81-100Yrs) |
4.870600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.396800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.574000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.419180E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.970480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.574800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.183000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.676800E-01 |
| Normal-VS-Type2 PRCC |
2.004800E-01 |
| Normal-VS-KIRP CIMP |
2.394800E-01 |
| Normal-VS-Unclassified PRCC |
2.357800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.389440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.639000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.545600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.401630E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.666300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.260000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.045400E-01 |
| Normal-vs-N1 |
3.980600E-01 |
| Normal-vs-N2 |
4.349800E-01 |
| N0-vs-N1 |
1.482220E-01 |
| N0-vs-N2 |
6.027400E-01 |
| N1-vs-N2 |
3.236200E-01 |
|
|
